49.24
Akero Therapeutics Inc Aktie (AKRO) Neueste Nachrichten
Teachers Retirement System of The State of Kentucky Decreases Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
How strong is Akero Therapeutics Inc. company’s balance sheetFree Daily Trading Room Entry - jammulinksnews.com
What makes Akero Therapeutics Inc. stock price move sharplyMarket Forecast Picks That Work - jammulinksnews.com
Is Akero Therapeutics Inc. a growth stock or a value stockUnlock expert trading strategies for growth - jammulinksnews.com
Jennison Associates LLC Invests $533,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Readystate Asset Management LP Acquires Shares of 100,500 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Holdings Lowered by Kennondale Capital Management LLC - MarketBeat
What analysts say about Akero Therapeutics Inc. stockTremendous growth potential - PrintWeekIndia
Is Akero Therapeutics Inc. a good long term investmentFast-track wealth growth - PrintWeekIndia
What drives Akero Therapeutics Inc. stock priceHigh-margin investment plays - PrintWeekIndia
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Bank of New York Mellon Corp - MarketBeat
AstraZeneca’s Anselamimab Misses Primary Endpoint in Amyloidosis Trials, Shows Promise in Subgroup - Insider Monkey
Is Akero Therapeutics Inc. stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com
How to Take Advantage of moves in (AKRO) - news.stocktradersdaily.com
Edgestream Partners L.P. Acquires Shares of 6,947 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - Autocar Professional
5,565 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Bought by Xponance Inc. - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $529,500.00 in Stock - MarketBeat
257,025 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Purchased by Principal Financial Group Inc. - MarketBeat
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - The Globe and Mail
Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Average Price Target from Analysts - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):